Envista Holdings (NVST) Total Current Liabilities (2018 - 2026)
Envista Holdings (NVST) recorded quarterly Total Current Liabilities of $786.6 million in Q2 2026, down 7.74% quarter-over-quarter from $852.6 million in Q4 2025, and down 9.93% on a YoY basis from $873.3 million in Q2 2025.
Envista Holdings (NVST) Total Current Liabilities (2018 - 2026) Analysis & Trends
Envista Holdings' Total Current Liabilities history runs 9 years deep, the most recent figure standing at $786.6 million for Q2 2026.
- In Q2 2026, Total Current Liabilities fell 9.93% year-over-year to $786.6 million; the TTM figure through Apr 2026 stood at $786.6 million (down 9.93% YoY), while the FY2025 annual figure was $852.6 million, down 2.97% from the prior year.
- Total Current Liabilities was $786.6 million for Q2 2026 at Envista Holdings, down from $852.6 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $1.3 billion in Q3 2022 to a low of $746.8 million in Q3 2023.
- Historically, Total Current Liabilities has averaged $959.4 million across 5 years, with a median of $865.5 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Total Current Liabilities sank 40.65% in 2023, then increased 15.89% in 2024.
- A 5-year view of Total Current Liabilities shows it stood at $1.2 billion in 2022, then tumbled by 36.86% to $780.8 million in 2023, then rose by 12.54% to $878.7 million in 2024, then retreated by 2.97% to $852.6 million in 2025, then declined by 7.74% to $786.6 million in 2026.
- The last three Total Current Liabilities figures came in at $786.6 million (Q2 2026), $852.6 million (Q4 2025), and $821.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 1.91 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 8.51 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 2.54 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 1.35 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 674.00 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 3.35 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 1.80 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.91 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 3.69 Bn |
| 10 | Envista Holdings | 4.06 Bn | 2.98 Bn | 390.10 Mn | 786.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 786.60 Mn |
| Dec 31, 2025 | 852.60 Mn |
| Sep 26, 2025 | 821.70 Mn |
| Jun 27, 2025 | 793.90 Mn |
| Mar 28, 2025 | 873.30 Mn |
| Dec 31, 2024 | 878.70 Mn |
| Sep 27, 2024 | 865.50 Mn |
| Jun 28, 2024 | 821.40 Mn |
| Mar 29, 2024 | 781.30 Mn |
| Dec 31, 2023 | 780.80 Mn |
| Sep 29, 2023 | 746.80 Mn |
| Jun 30, 2023 | 1.15 Bn |
| Mar 31, 2023 | 1.15 Bn |
| Dec 31, 2022 | 1.24 Bn |
| Sep 30, 2022 | 1.26 Bn |
| Jul 1, 2022 | 1.26 Bn |
| Apr 1, 2022 | 1.26 Bn |
| Dec 31, 2021 | 1.21 Bn |
| Oct 1, 2021 | 1.27 Bn |
| Jul 2, 2021 | 1.16 Bn |